Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 732-739, 2003; 10.1373/49.5.732
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erali, M.
Right arrow Articles by Wittwer, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erali, M.
Right arrow Articles by Wittwer, C.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Hemostasis and Thrombosis
(Clinical Chemistry. 2003;49:732-739.)
© 2003 American Association for Clinical Chemistry, Inc.

Evaluation of Electronic Microarrays for Genotyping Factor V, Factor II, and MTHFR

Maria Erali1,a, Ben Schmidt1, Elaine Lyon1,2 and Carl Wittwer1,2

1 ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, 500 Chipeta Way, Salt Lake City, UT 84108.

2 Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132.

aAuthor for correspondence. Fax 801-584-5114; e-mail eralimc{at}aruplab.com.

Background: Genetic risk factors associated with venous thrombosis include mutations in the factor V (Leiden), factor II (prothrombin), and methylenetetrahydrofolate reductase (MTHFR) genes. We evaluated a method using electronically addressable microarrays for the detection of mutations in these genes that have been associated with vascular disease.

Methods: The NanoChip® Molecular Biology Workstation (Nanogen) uses electronic microarrays for mutation detection. Factor V, factor II, and MTHFR genotypes identified in the NanoChip system on 225 samples were compared with genotypes from LightCycler® assays (Roche). We determined within- and between-cartridge signal and ratio variation and analyzed the effect of additional mutations at or near the detection area used for the NanoChip assays.

Results: Genotypes determined for all three mutations on the NanoChip platform were in complete concordance with LightCycler results. Within-cartridge signal variation as measured by the CV of fluorescence signals was <10% for each allele when present. The within-cartridge CV for heterozygous mutant/wild-type ratios was <8.5%, and between-cartridge CV was <18%. A dilution study showed that results could be obtained in this assay with 6 ng of nucleic acid per PCR, the lowest input tested. The presence of additional sequence variations near the expected mutations can produce equivocal or discrepant results.

Conclusions: Mutation detection using the NanoChip Molecular Biology Workstation was accurate and reproducible for the three assays evaluated.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
H.-K. Lee, L. D. Lewis, G. J. Tsongalis, B. C. Schur, P. J. Jannetto, S. H. Wong, and K.-T. J. Yeo
Validation of a CYP2D6 Genotyping Panel on the NanoChip Molecular Biology Workstation
Clin. Chem., May 1, 2007; 53(5): 823 - 828.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Lyon
Discovering Rare Variants by Use of Melting Temperature Shifts Seen in Melting Curve Analysis
Clin. Chem., August 1, 2005; 51(8): 1331 - 1332.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. G. Tag, M.-C. Schifflers, M. Mohnen, A. M. Gressner, and R. Weiskirchen
Atypical Melting Curve Resulting from Genetic Variation in the 3' Untranslated Region at Position 20218 in the Prothrombin Gene Analyzed with the LightCycler Factor II (Prothrombin) G20210A Assay
Clin. Chem., August 1, 2005; 51(8): 1560 - 1561.
[Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
N. A. Saunders, S. Alexander, and I. Tatt
env Gene Typing of Human Immunodeficiency Virus Type 1 Strains on Electronic Microarrays
J. Clin. Microbiol., April 1, 2005; 43(4): 1910 - 1916.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Bortolin, M. Black, H. Modi, I. Boszko, D. Kobler, D. Fieldhouse, E. Lopes, J.-M. Lacroix, R. Grimwood, P. Wells, et al.
Analytical Validation of the Tag-It High-Throughput Microsphere-Based Universal Array Genotyping Platform: Application to the Multiplex Detection of a Panel of Thrombophilia-Associated Single-Nucleotide Polymorphisms
Clin. Chem., November 1, 2004; 50(11): 2028 - 2036.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Frusconi, B. Giusti, L. Rossi, S. Bernabini, F. Poggi, I. Giotti, R. Abbate, G. Pepe, and F. Torricelli
Improvement of Low-Density Microelectronic Array Technology to Characterize 14 Mutations/Single-Nucleotide Polymorphisms from Several Human Genes on a Large Scale
Clin. Chem., April 1, 2004; 50(4): 775 - 777.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.